A member of the Gambian Red Cross looks through sacks of collected cough syrups in Banjul.Image source, Getty Images
Image caption, A member of the Gambian Red Cross looks through sacks of cough syrups that have been collected

The makers of cough syrups have been ordered to stop production by Indian health officials after they were linked to the deaths of children.

The Indian regulators found that the company broke rules in manufacturing and testing.

A global alert was issued by the WHO over four of the cough syrups.

There are investigations going on in India and The Gambia.

The New Delhi-based firm had been found to have broken a number of safety rules.

They said that this was done in view of the seriousness of the contraventions observed during the investigation and its potential risk to the quality, safety and efficacy of the drug beingproduced.

They did not respond to the request.

The company said last week that it was shocked to hear about the deaths and that it was sad.

The WHO issued a global alert over four of Maiden's cough syrups, warning that they could be linked to injuries and deaths.

The products may have been distributed through informal markets to other countries and regions.

The medicines were identified as Promethazine Oral Solution.

The deaths of the children are being investigated by police in the country.

Adama Barrow stated that authorities would leave no stone unturned in their investigation.

The cough syrups were imported from a US company, according to a police report.

The majority of the contaminated syrups that were imported into the country had been seized, according to the report.

Media caption,

There are deaths and cough syrup in the country.

  • The Gambia
  • Healthcare
  • Pharmaceutical industry
  • India